16545-6 |
Capreomycin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Capreomycin [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16545-6 |
|
|
|
|
Both |
|
|
|
0 |
Capreomycin SerPl-mCnc |
|
|
|
Y |
|
CAPASTAT; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Ogostal; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16546-4 |
Captopril |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Captopril [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16546-4 |
|
|
|
|
Both |
|
|
|
0 |
Captopril SerPl-mCnc |
|
|
|
Y |
|
c246; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16547-2 |
Carbamate pesticides |
Type |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Carbamate pesticides [Type] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16547-2 |
|
|
|
|
Both |
|
|
|
0 |
Carbamate pesticides Ur |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Nominal; Point in time; Random; Typ; UA; UR; Urn |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
16548-0 |
carBAMazepine |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
carBAMazepine [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16548-0 |
|
|
|
|
Both |
|
|
|
0 |
carBAMazepine Ur-mCnc |
|
|
|
Y |
|
Carbamazapine; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tegretol; Teril; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16549-8 |
Carbinoxamine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Carbinoxamine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16549-8 |
|
|
|
|
Both |
|
|
|
0 |
Carbinoxamine Ur Ql |
|
|
|
|
|
C16H19ClN2O; Clistin; DRUG/TOXICOLOGY; Drugs; Ordinal; Palgic; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1655-0 |
11-Deoxy/11-Oxy steroids |
MCrto |
Urine |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated 11-Deoxy/11-Oxy steroids in Urine |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
1655-0 |
|
|
|
|
|
|
|
|
0 |
Deprecated 11-Deoxy/11-Oxy Ur-mRto |
|
|
|
Y |
|
Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Ste; Steriods; Steroid; UA; UR; Urn |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16550-6 |
Carbohydrates |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Carbohydrates [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16550-6 |
|
|
|
|
Both |
|
|
|
0 |
Carbohydrates Ur |
|
|
|
|
|
Carbohydrate; Chemistry; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
16551-4 |
Carbon dioxide |
SCnc |
BldC |
Pt |
Qn |
|
|
ACTIVE |
Carbon dioxide, total [Moles/volume] in Capillary blood |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
16551-4 |
|
|
|
|
Both |
|
|
|
0 |
CO2 BldC-sCnc |
|
|
|
Y |
|
Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Finger stick; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2 |
2.73 |
1.0l |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
16553-0 |
Carnitine |
MCnt |
Tiss |
Pt |
Qn |
|
|
DISCOURAGED |
Carnitine [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16553-0 |
|
|
|
|
Both |
|
|
|
0 |
Carnitine Tiss-mCnt |
|
|
|
Y |
|
Carnitine.total; Chemistry; Mass Content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.42 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16555-5 |
Carnitine |
MCnc |
CSF |
Pt |
Qn |
|
|
DISCOURAGED |
Carnitine [Mass/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16555-5 |
|
|
|
|
Both |
|
|
|
0 |
Carnitine CSF-mCnc |
|
|
|
Y |
|
Carnitine.total; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.42 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16556-3 |
Carnitine |
MCnc |
Amnio fld |
Pt |
Qn |
|
|
DISCOURAGED |
Carnitine [Mass/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16556-3 |
|
|
|
|
Both |
|
|
|
0 |
Carnitine Amn-mCnc |
|
|
|
Y |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Carnitine.total; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16557-1 |
Carnosine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Carnosine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16557-1 |
|
|
|
|
Observation |
|
|
|
0 |
Carnosine Ur Ql |
|
|
|
|
|
Car; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16558-9 |
Catecholamines^2H post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in Plasma --2 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
16558-9 |
|
|
|
|
Observation |
|
|
|
0 |
Catechols 2h p chal Plas-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; CHEMISTRY.CHALLENGE TESTING; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0l |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
16559-7 |
Catecholamines^3H post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in Plasma --3 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
16559-7 |
|
|
|
|
Observation |
|
|
|
0 |
Catechols 3h p chal Plas-mCnc |
|
|
|
Y |
|
3h p chal; After; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; CHEMISTRY.CHALLENGE TESTING; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0l |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
1656-8 |
11-Deoxycorticosterone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHEM |
|
1656-8 |
|
|
|
|
Both |
|
|
|
0 |
11DOC SerPl-mCnc |
|
|
|
Y |
|
11DOC; 11-DOC; 21-Hydroxyprogesterone; Chemistry; DOC; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
16560-5 |
Catecholamines^5th specimen post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in Plasma --5th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
16560-5 |
|
|
|
|
Observation |
|
|
|
0 |
Catechols sp5 p chal Plas-mCnc |
|
|
|
Y |
|
After; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; CHEMISTRY.CHALLENGE TESTING; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp5; sp5 p chal; Spec |
2.5 |
1.0l |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
16561-3 |
Catecholamines^6th specimen post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in Plasma --6th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
16561-3 |
|
|
|
|
Observation |
|
|
|
0 |
Catechols sp6 p chal Plas-mCnc |
|
|
|
Y |
|
After; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; CHEMISTRY.CHALLENGE TESTING; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp6; sp6 p chal; Spec |
2.5 |
1.0l |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
16562-1 |
Cathartic laxatives |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Cathartic laxatives [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16562-1 |
|
|
|
|
Both |
|
|
|
0 |
Cathartic laxatives Ur |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Laxative; Nominal; Point in time; Random; UA; UR; Urn |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
16563-9 |
Cathepsin D |
SFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cathepsin D in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
16563-9 |
|
|
|
|
Observation |
|
|
|
0 |
Cathepsin D SFr SerPl |
|
|
|
Y |
|
Chemistry; CTG; Dextro; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction |
2.7 |
1.0l |
|
|
|
|
|
|
|
% |
|
|
|
0 |
16564-7 |
Cefaclor |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cefaclor [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16564-7 |
|
|
|
|
Both |
|
|
|
0 |
Cefaclor SerPl-mCnc |
|
|
|
Y |
|
Alfatil; c7; Ceclor; Distaclor; DRUG/TOXICOLOGY; Drugs; Kefalor; Level; Mass concentration; Panacef; Panoral; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc7; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16565-4 |
Cefadroxil |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cefadroxil [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16565-4 |
|
|
|
|
Both |
|
|
|
0 |
Cefadroxil SerPl-mCnc |
|
|
|
Y |
|
Bidocef; Cefadril; Cefadrox; Cefamox; Cefroxil; Cehpos; Ceoxil; Crenodyn; Droxicef; DRUG/TOXICOLOGY; Drugs; Duracef; Duricef; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16566-2 |
ceFAZolin |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
ceFAZolin [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16566-2 |
|
|
|
|
Both |
|
|
|
0 |
ceFAZolin Ur-mCnc |
|
|
|
Y |
|
Ancef; C32; Cefamezin; DRUG/TOXICOLOGY; Drugs; Kefj; Kefzol; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Totacef; UA; UR; Urn; Zolicef |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16567-0 |
Cefixime |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cefixime [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16567-0 |
|
|
|
|
Both |
|
|
|
0 |
Cefixime SerPl-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Suprax |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16568-8 |
Cefuroxime Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Cefuroxime IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
16568-8 |
|
|
|
|
Both |
|
|
|
0 |
Cefuroxime IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c308; C33; Ceftin; Cefuroxime Axetil; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Zinacef |
2.42 |
1.0l |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
16569-6 |
cefTRIAXone Ab.IgE |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
cefTRIAXone IgE Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
16569-6 |
|
|
|
|
Both |
|
|
|
0 |
cefTRIAXone IgE-mCnc |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c9; Immune globulin E; Immunoglobulin E; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rocephin; ROCJ; Serum; SR |
2.34 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |